MS177 is a cereblon-recruiting PROTAC degrader targeting EZH2, the catalytic component of polycomb repressive complex two. Public sources describe it as a molecule composed of a CRBN ligand, a linker, and a potent enzymatic EZH2 inhibitor-derived target-binding element. The EZH2-recognition module engages the methyltransferase target, while the cereblon ligand recruits the CRL4-cereblon E3 ligase complex for proximity-induced ubiquitination. Mechanistically, MS177 depletes both canonical EZH2–PRC2 and noncanonical EZH2–cMyc complexes, enabling functional interrogation of EZH2 protein roles beyond catalytic methyltransferase inhibition. It is useful for studying PRC2 biology, H3K27 methylation regulation, EZH2-dependent transcriptional states, leukemia-cell responses, immune-responsive gene activation, and the differences between enzymatic inhibition and whole-protein degradation of chromatin regulatory targets.
Structure of 2225938-86-1
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Target: Targets EZH2 and associated PRC2 chromatin-regulatory complexes for experimental targeted protein degradation studies.
Binding Site: Binds the EZH2 ligand-binding region and cereblon thalidomide-binding pocket to support productive ternary complex formation.
Mechanism of Action: MS177 is designed for use in PROTAC or targeted protein degradation experiments directed toward EZH2 and associated PRC2 chromatin-regulatory complexes. The bifunctional molecule links a target-recognition element to cereblon, promoting proximity between the protein of interest and ubiquitination machinery. Productive ternary-complex formation can drive polyubiquitination and proteasome-dependent target depletion, allowing researchers to compare pharmacological inhibition with protein removal. It is suitable for evaluating degradation potency, kinetics, pathway selectivity, and downstream signaling consequences in engineered or disease-relevant cellular models.
Applications• PROTAC-Mediated Kinase Degradation: MS177 is utilized in the selective degradation of specific kinases, allowing researchers to study the downstream effects of kinase removal. This application aids in elucidating kinase-dependent signaling pathways and identifying potential therapeutic targets within cellular processes.
• Targeted Protein Degradation in Cancer Research: By employing MS177, researchers can achieve the targeted degradation of oncogenic proteins. This approach is instrumental in investigating the role of these proteins in tumor progression and offers insights into novel cancer treatment strategies.
• Investigating Protein-Protein Interactions: MS177 facilitates the degradation of proteins involved in complex interactions, enabling the study of the functional consequences of disrupting these interactions. This application is crucial for understanding the dynamic nature of protein networks and their impact on cellular function.
• Cellular Pathway Analysis via PROTACs: MS177 is employed to degrade specific proteins, providing a tool to dissect cellular pathways and understand their regulation. This application is vital for mapping out critical nodes and feedback mechanisms within various biological systems.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.